Dyspepsia and irritable bowel syndrome in China: A population-based endoscopy study of prevalence and impact

Alimentary Pharmacology and Therapeutics

Volumn 32, Issue 4, 2010, Pages 562-572

  Zhao, Y ^a   Zou, D ^b   Wang, R ^a   Ma, X ^a   Yan, X ^a   Man, X ^b   Gao, L ^b   Fang, J ^c   Yan, H ^d   Kang, X ^e   Yin, P ^f   Hao, Y ^c   Li, Q ^d   Dent, J ^g   Sung, J ^h   Halling, K ⁱ   Wernersson, B ⁱ   Johansson, S ⁱ   He, J ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

^d XI'AN JIAOTONG UNIVERSITY   (China)

^e PEKING UNIVERSITY   (China)

^f HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^g ROYAL ADELAIDE HOSPITAL   (Australia)

^h CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

ⁱ ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; ATROPHIC GASTRITIS; BLOOD ANALYSIS; CHINA; CONFIDENCE INTERVAL; CONSTIPATION; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE ASSOCIATION; DYSPEPSIA; EMOTION; ENDOSCOPY; ESOPHAGOGASTRODUODENOSCOPY; FAMILY HISTORY; FEMALE; GASTROINTESTINAL MOTILITY DISORDER; GENDER; GROUPS BY AGE; HEALTH STATUS; HELICOBACTER INFECTION; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PAIN; PEPTIC ULCER; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REFLUX ESOPHAGITIS; RISK; SEROLOGY; SHORT FORM 36; SOCIAL STATUS;

ADULT; AGED; AGED, 80 AND OVER; CHINA; COHORT STUDIES; DYSPEPSIA; ENDOSCOPY; FEMALE; HEALTH STATUS; HELICOBACTER INFECTIONS; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 77954714064     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2010.04376.x     Document Type: Article

References (35)

1. Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology 2006 130:1466 1479.
2. Hungin APS, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther 2003 17:643 650.
3. Saito YA, Schoenfeld P, Locke GR 3rd. The epidemiology of irritable bowel syndrome in North America: a systematic review. Am J Gastroenterol 2002 97:1910 1915.
4. Quigley EM, Bytzer P, Jones R, Mearin F. Irritable bowel syndrome: the burden and unmet needs in Europe. Dig Liver Dis 2006 38:717 723.
5. Zagari RM, Pozzato P, Damian S, et al. The epidemiology of irritable bowel syndrome and its relationship with gastroesophageal reflux disease in the general population: results from the Loiano-Monghidoro study. Gastroenterology 2006 4 (Suppl 2 S1132.
6. Morbidity Statistics From General Practice: Fourth National Study 1991-1992.
7. Hu WH, Wong WM, Lam CL, et al. Anxiety but not depression determines health care-seeking behaviour in Chinese patients with dyspepsia and irritable bowel syndrome: a population-based study. Aliment Pharmacol Ther 2002 16:2081 2088.
8. Lau EM, Chan FK, Ziea ET, Chan CS, Wu JC, Sung JJ. Epidemiology of irritable bowel syndrome in Chinese. Dig Dis Sci 2002 47:2621 2624.
9. Kwan AC, Hu WH, Chan YK, Yeung YW, Lai TS, Yuen H. Prevalence of irritable bowel syndrome in Hong Kong. J Gastroenterol Hepatol 2002 17:1180 1186.
10. Ford AC, Marwaha A, Lim A, Moayyedi P. Systematic review and meta-analysis of the prevalence of irritable bowel syndrome in individuals with dyspepsia. Clin Gastroenterol Hepatol 2010 8:401 409.
11. Wang A, Liao X, Xiong L, et al. The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria. BMC Gastroenterol 2008 8:43.
12. Yan X, Wang R, Zhao Y, et al. Systematic investigation of gastrointestinal diseases in China (SILC): validation of survey methodology. BMC Gastroenterol 2009 9:86.
13. Cao Y, Yan X, Ma X, et al. Validation of a survey methodology for gastroesophageal reflux disease in China. BMC Gastroenterol 2008 8:37.
14. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN. Functional gastroduodenal disorders. Gut 1999 45 (Suppl 2 II37 42.
15. Kwan AC, Bao TN, Chakkaphak S, et al. Validation of Rome II criteria for functional gastrointestinal disorders by factor analysis of symptoms in Asian patient sample. J Gastroenterol Hepatol 2003 18:796 802.
16. Vakil N, Veldhuyzen van Zanten S, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastro-esophageal reflux disease (GERD) - a global evidence-based consensus. Am J Gastroenterol 2006 101:1900 1920.
17. Drossman DA, Corazziari E, Talley N, Thompson WG, Whitehead WE. Rome II: A multinational consensus document on functional gastrointestinal disorders. Gut 1999 45 (Suppl 2 II1 81.
18. Ware JE Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992 30:473 483.
19. Ware JE. SF-36 Health Survey: Manual and Interpretation Guide.
20. Yan X, Wang R, Ma X, et al. Validation of a survey methodology for the Systematic Investigation of gastrointestinaL diseases in China (SILC) epidemiological study. Gastroenterol 2009 136 (Suppl 1 W1028.
21. Zou D, He J, Chen J, et al. Epidemiology of gastroesophageal reflux disease and esophagitis: the Systematic Investigation of gastrointestinaL diseases in China (SILC) study. Gastroenterol 2009 136 (Suppl 1 S1911.
22. Wallander MA, Johansson S, Ruigómez A, García Rodríguez LA, Jones R. Dyspepsia in general practice: incidence, risk factors, comorbidity and mortality. Fam Pract 2007 24:403 411.
23. Vandvik PO, Lydersen S, Farup PG. Prevalence, comorbidity and impact of irritable bowel syndrome in Norway. Scand J Gastroenterol 2006 41:650 656.
24. Ruigómez A, Wallander MA, Johansson S, García Rodríguez LA. Irritable bowel syndrome and gastroesophageal reflux disease in primary care: is there a link? Dig Dis Sci 2009 54:1079 1086.
25. Aro P, Storskrubb T, Ronkainen J, et al. Peptic ulcer disease in a general adult population: the Kalixanda study: a random population-based study. Am J Epidemiol 2006 163:1025 1034.
26. Ronkainen J, Aro P, Storskrubb T, et al. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol 2005 40:275 285.
27. Zagari RM, Fuccio L, Wallander MA, et al. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: Loiano-Monghidoro study. Gut 2008 57:1354 1359.
28. Wong BCY, Kinoshita Y. Systematic review on epidemiology of gastroesophageal reflux disease in Asia. Clin Gastroenterol Hepatol 2006 4:398 407.
29. Li Z, Zou D, Chen J, et al. Epidemiology of peptic ulcer: the Systematic Investigation of gastrointestinaL diseases in China (SILC) study. Gastroenterol 2009 136 (Suppl 1 S1088.
30. Lembo A, Zaman M, Jones M, Talley NJ. Influence of genetics on irritable bowel syndrome, gastro-oesophageal reflux and dyspepsia: a twin study. Aliment Pharmacol Ther 2007 25:1343 1350.
31. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006 130:1377 1390.
32. Halling K, Kulich K, Carlsson J, Wiklund I. An international comparison of the burden of illness in patients with dyspepsia. Dig Dis 2008 26:264 273.
33. Longstreth GF, Bolus R, Naliboff B, et al. Impact of irritable bowel syndrome on patients' lives: development and psychometric documentation of a disease-specific measure for use in clinical trials. Eur J Gastroenterol Hepatol 2005 17:411 420.
34. Barbara G, De Giorgio R, Stanghellini V, Cremon C, Salvioli B, Corinaldesi R. New pathophysiological mechanisms in irritable bowel syndrome. Aliment Pharmacol Ther 2004 20 (Suppl 2 1 9. (Pubitemid 39237523)
35. Gilkin RJ Jr. The spectrum of irritable bowel syndrome: a clinical review. Clin Ther 2005 27:1696 1709.